Firebrick Pharma Limited (ASX:FRE)
Australia · Delayed Price · Currency is AUD 0.0420
0.00 (0.00%)
Jun 4, 2026, 3:23 PM AEST
Firebrick Pharma Market Cap
Firebrick Pharma has a market cap or net worth of 11.96 million as of June 5, 2026. Its market cap has decreased by -46.05% in one year.
Market Cap
11.96M
Enterprise Value
10.52M
Revenue
410.70K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since January 28, 2022, Firebrick Pharma's market cap has decreased from 89.49M to 11.96M, a decrease of -86.64%. That is a compound annual growth rate of -37.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 11.96M | -9.87% |
| Dec 30, 2025 | 13.27M | 1.87% |
| Dec 31, 2024 | 13.03M | 46.33% |
| Dec 29, 2023 | 8.90M | -77.12% |
| Dec 29, 2022 | 38.92M | -56.51% |
| Jan 28, 2022 | 89.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 44.92B |
| Sigma Healthcare | 33.01B |
| Pro Medicus | 16.72B |
| Sonic Healthcare | 9.24B |
| Immuron | 15.03M |
| OncoSil Medical | 13.97M |
| Adheris Health | 12.11M |
| Cambium Bio | 12.03M |